Global Radiopharmaceutical Market 2012-2016 Reports
DALLAS, Nov. 14, 2013 /PRNewswire-iReach/ -- ReportsnReports.com adds Global Radiopharmaceutical Market 2012-2016 research report to its store.
Analysts forecast the Global Radiopharmaceutical market to grow at a CAGR of 18.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Radio Pharmaceutical market has also been witnessing the increasing demand for radiopharmaceuticals. However, the short half-life could pose a challenge to the growth of this market.
Global Radiopharmaceutical Market 2012-2016 report is available at http://www.reportsnreports.com/reports/270658-global-radiopharmaceutical-market-2012-2016.html.
The Global Radiopharmaceutical Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Radiopharmaceutical market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Cardinal Health Inc., Covidien plc, Lantheus Medical Imaging Inc., and IBA Molecular Inc.
Other vendors mentioned in the report are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Algeta ASA, Bio-Nucleonics Inc., GE Healthcare Ltd., Monrol Nuclear Products Inc., Molecular Insight Pharmaceuticals Inc., Nordion Inc., Novelos Therapeutics Inc., NTP Radioisotopes (Pty) Ltd., Positron Corp., and Siemens Healthcare. Order a copy of this report at http://www.reportsnreports.com/purchase.aspx?name=270658.
Key questions answered in these market research reports:
- What will the market size be in 2016 and what will be the growth rate?
- What are key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by key vendors?
- What are the strengths and weaknesses of each of these key vendors?
Table of Contents:
- Executive Summary
- Scope of the Report
- Market Research Methodology
- List of Abbreviations
- Market Landscape
- Global Radiopharmaceuticals Market Segmentation by Application
- Geographical Segmentation
- Key Leading Countries
- Buying Criteria
- Market Growth Drivers
- Drivers and their Impact
- Market Challenges
- Impact of Drivers and Challenges
- Market Trends
- Trends and their Impact
- Vendor Landscape
- Other Reports in this Series
List of Exhibits provided in the Global Radiopharmaceutical Market Report include:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Radiopharmaceuticals Market 2012-2016 (US $ billion)
Exhibit 3: Global Radiopharmaceuticals Market Segmentation by Application
Exhibit 4: Global Radiopharmaceuticals Market Segmentation Based on Application 2012
Exhibit 5: Global Radiopharmaceuticals Market Segmentation Based on Application 2016
Exhibit 6: Global Diagnostic Radiopharmaceuticals Market 2012-2016 (US$ billion)
Exhibit 7: Global Therapeutics Radiopharmaceuticals Market 2012-2016 (US$ billion)
Exhibit 8: Global Radiopharmaceuticals Market by Geographical Segmentation 2012
Exhibit 9: Global Radiopharmaceuticals Market by Vendor Segmentation 2012
Exhibit 10: Business Segmentation of Covidien plc
Exhibit 11: Business Segmentation of Cardinal Healthcare Inc.
Exhibit 12: Business Segmentation of IBA Molecular Inc.
Explore more reports Pharmaceuticals Market at http://www.reportsnreports.com/market-research/pharmaceuticals/.
Media Contact: Priyank Tiwari, ReportsnReports, +1 888 391 5441, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com